triciribine has been researched along with Proliferative Vitreoretinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, RB; Ford, E; Liu, F; Narayanan, SP; Shan, S; Somanath, PR | 1 |
1 other study(ies) available for triciribine and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathy.
Topics: Animals; Animals, Newborn; Capillary Permeability; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oxygen; Retinal Diseases; Retinal Neovascularization; Vascular Endothelial Growth Factor A; Vitreoretinopathy, Proliferative | 2023 |